Showing 1541-1550 of 8918 results for "".
Update on Diagnosis and Topical Management of Erythrasma
https://practicaldermatology.com/topics/general-topics/PD0909_03-php/22767/This under-diagnosed cutaneous infection is caused by a bacterium but may respond to anti-fungal therapies.Which Probiotic for Which Disease? Part 2
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-2/23596/The conclusion of this 2-part series reviews the research for probiotics in the management of AD, acne, and psoriasis.Inflamed Feelings: The Psychological Effects of Inflammatory Disorders
https://practicaldermatology.com/topics/psoriasis/PD0309_05-php/22859/Data suggest that children and adults suffering from chronic inflammatory skin diseases, such as eczema and psoriasis, are at higher risk for depression, anxiety, and other psychiatric illnesses.The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.New Oral Agent May Shift Psoriasis Treatment Landscape
https://practicaldermatology.com/topics/psoriasis/new-oral-agent-may-shift-psoriasis-treatment-landscape/21258/A notable approval in 2014, apremilast may play an important role in bridging a wide gap in the care of moderate to severe psoriasis.The Microbiome and Its Impact on Antibiotic Use in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-microbiome-and-its-impact-on-antibiotic-use-in-dermatology/23278/Despite focus on the clinical consequences of overusing antibiotics for decades, relatively little has been said about the potential impact on the microbiome.BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianAdvances in the Treatment of Reticular Erythematous Mucinosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/advances-in-the-treatment-of-reticular-erythematous-mucinosis/23491/Considering nicotinamide’s anti-inflammatory properties for inflammatory dermatological conditions to avoid steroid and antibiotic overuse.DataDerm Update
https://practicaldermatology.com/topics/practice-management/dataderm-update/23891/Joining can do a lot for your practice and patients.It is Time to Move Beyond Mushroom Tyrosinase. And Is Hydroquinone What We Think It Is?
https://practicaldermatology.com/topics/pigmentary-disorders/it-is-time-to-move-beyond-mushroom-tyrosinase-and-is-hydroquinone-what-we-think-it-is/23768/New research is offering better clinical clues about the action of tyrosinase inhibitors.